Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies Journal Article


Authors: Forero-Torres, A; Bartlett, N. L.; Berryman, R. B.; Chen, R; Matous, J. V.; Fanale, M. A.; O'Connor, O. A.; Olshefski, R.; Smith, S. E.; Huebner, D.; Levine, P. L.; Grove, L. E.; Gopal, A. K.
Article Title: Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies
Journal Title: Leukemia lymphoma
Volume: 56
Issue: 4
ISSN: 1029-2403; 1026-8022
Publisher: Unknown  
Journal Place: England
Date Published: 2015
Start Page: 1151
End Page: 1153
Language: eng
DOI/URL:
Notes: LR: 20161125; JID: 9007422; 0 (Antigens, CD30); 0 (Immunoconjugates); 7XL5ISS668 (brentuximab vedotin); ppublish
LUC Authors
  1. Scott Smith
    38 Smith